PHC2-AS1: A Potential Drug Target and Biomarker (G101929464)

Target Name: PHC2-AS1

NCBI ID: G101929464

PHC2-AS1

Other Name(s): PHC2 antisense RNA 1

PHC2-AS1: A Potential Drug Target and Biomarker

PHC2-AS1 is a unique RNA molecule that has been identified as a potential drug target and biomarker. It is derived from the PHC2 gene, which encodes a protein involved in the intracellular signaling pathway known as the Phosphatidylinositol (PI) signaling pathway. This pathway is critical for various cellular processes, including cell signaling, inflammation, and metabolism.PHC2-AS1 has been shown to play a significant role in the regulation of cellular processes, including cell adhesion, migration, and the development of cancer.

The PHC2-AS1 molecule has several unique features that make it an attractive drug target. Firstly, it is a non-coding RNA molecule that can be easily modified to create a cDNA or RNA interference (RNAi) construct. This allows researchers to easily deliver the PHC2-AS1 molecule to cells and block its activity. Secondly, the PHC2-AS1 molecule has a unique structure that is not found in other RNA molecules. It has a stem-loop structure that is composed of three loops and a central stem. This unique structure allows the PHC2-AS1 molecule to interact with other molecules and participate in various cellular processes.

PHC2-AS1 has been shown to play a role in the regulation of cellular processes by interacting with various cellular signaling pathways. One of the most significant processes that PHC2-AS1 has been shown to regulate is the PI signaling pathway. This pathway is critical for the regulation of cell signaling, including the regulation of cell growth, differentiation, and survival.PHC2-AS1 has been shown to play a role in the regulation of the PI signaling pathway by binding to the protein called PIK3C, which is a key regulator of this pathway.

PHC2-AS1 has also been shown to play a role in the regulation of cell adhesion. Adhesion is a critical process that allows cells to stick together and form tissues. PHC2-AS1 has been shown to play a role in the regulation of cell adhesion by binding to the protein called E-cadherin, which is a critical adhesion molecule.

PHC2-AS1 has also been shown to play a role in the regulation of cell migration. Migration is a critical process that allows cells to move towards new environments and perform various cellular functions. PHC2-AS1 has been shown to play a role in the regulation of cell migration by binding to the protein called vimentin, which is a critical regulator of cell migration.

PHC2-AS1 has also been shown to play a role in the regulation of cellular processes that are associated with the development of cancer.PHC2-AS1 has been shown to promote the growth and survival of cancer cells, and it is also involved in the regulation of the angiogenesis that is the process by which cancer cells obtain the blood supply.

In conclusion, PHC2-AS1 is a unique RNA molecule that has been shown to play a significant role in the regulation of cellular processes. Its unique structure and ability to interact with various molecules make it an attractive drug target and biomarker. Further research is needed to fully understand the role of PHC2-AS1 in cellular processes and its potential as a drug.

Protein Name: PHC2 Antisense RNA 1

The "PHC2-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PHC2-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets